Skip to content

A randomized, prospective controlled pilot study between UKA and TKA

A randomized, prospective controlled pilot study between UKA and TKA - UKA/TKA Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000010221
Enrollment
20
Registered
2013-03-12
Start date
2013-03-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bilateral Medial Knee Osteoarthritis

Interventions

Perform UKA first Perform TKA first

Sponsors

Zimmer K.K.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1). Patient is 20 to 70 years of age at the Informed Consent (IC), inclusive 2). Both males and females 3). Patient qualifies for bilateral primary medial UKA due to bilateral unicompartmental knee osteoarthritis (Do not want to randomly implant a UKA in a patient who requires TKA) 4). Patient has more than 120 degree pre-op Range of Motion (ROM) 5). Patient expect load bearing ROM to be less than or equal to 155 degrees 6). Patient with flexion contracture less than 15 degree 7). Patient with preserved lateral compartment and patellofemoral joint 8). Patient with varus deformity less than 15 degree (Valgus deformities will be excluded from this study) 9). Patient with not significant obesity defined with a Body Mass Index (BMI) of <40 10). Patient has no osteophyte in intercondylar notch 11). Patient has intact anterior cruciate ligaments 12). Patient is willing and able to provide the written IC by signing and dating the Independent Ethics Committee (IEC) approved IC form 13). Patient is willing and able to complete scheduled study procedures and follow-up evaluations 14). Japanese

Exclusion criteria

Exclusion criteria: 1). Patient is currently participating in any other surgical intervention studies or pain management studies 2). Patient with previous history of infection in the affected joint and/or local/systemic infection that may affect the prosthetic joint 3). Patient with insufficient bone stock on femoral or tibial surfaces 4). Patient with skeletal immaturity 5). Patient with neuropathic arthropathy 6). Patient with chondrocalcinosis 7). Patient with osteoporosis or any loss of musculature or neuromuscular disease that compromises the affected limb 8). Patient with damage to the articular cartilage of the opposite compartment 9). Patient with inflammatory synovitis 10). Patient with eburnation in the patellofemoral joint 11). Patient with a stable, painless arthrodesis in a satisfactory functional position 12). Patient with severe instability secondary to the absence of collateral ligament integrity 13). Patient with an ulcer of the skin or a history of recurrent breakdown of the skin 14). Patient with history of deep vein thrombosis (DVT) or pulmonary embolism (PE) 15). Patient has a known or suspected sensitivity or allergy to one or more of the implant materials 16). Patient is pregnant or considered a member of a protected population (e.g., prisoner, mentally incompetent, etc.)

Design outcomes

Primary

MeasureTime frame
2011 Knee Society Score

Secondary

MeasureTime frame
Radiographic Assessment, Clinical Assessments and Safety Assessment

Countries

Japan

Contacts

Public ContactAkira Kashima

Zimmer K.K. Clinical Affairs

akira.kashima@zimmer.com03-6402-6610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026